181 related articles for article (PubMed ID: 37887278)
61. Glucocorticoid receptor and Histone deacetylase 6 mediate the differential effect of dexamethasone during osteogenesis of mesenchymal stromal cells (MSCs).
Rimando MG; Wu HH; Liu YA; Lee CW; Kuo SW; Lo YP; Tseng KF; Liu YS; Lee OK
Sci Rep; 2016 Nov; 6():37371. PubMed ID: 27901049
[TBL] [Abstract][Full Text] [Related]
62. Blocking glucocorticoid signaling in osteoblasts and osteocytes prevents mechanical unloading-induced cortical bone loss.
Yang J; Li J; Cui X; Li W; Xue Y; Shang P; Zhang H
Bone; 2020 Jan; 130():115108. PubMed ID: 31704341
[TBL] [Abstract][Full Text] [Related]
63. [Glucocorticoid-induced osteoporosis].
Tóth M; Tulassay Z
Orv Hetil; 2000 Jan; 141(5):219-23. PubMed ID: 10697979
[TBL] [Abstract][Full Text] [Related]
64. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells.
Matsumoto Y; Otsuka F; Takano M; Mukai T; Yamanaka R; Takeda M; Miyoshi T; Inagaki K; Sada KE; Makino H
Mol Cell Endocrinol; 2010 Aug; 325(1-2):118-27. PubMed ID: 20638987
[TBL] [Abstract][Full Text] [Related]
65. Glucocorticoid Signaling and Bone Biology.
Komori T
Horm Metab Res; 2016 Nov; 48(11):755-763. PubMed ID: 27871116
[TBL] [Abstract][Full Text] [Related]
66. Glucocorticoids and the osteoclast.
Kim HJ; Zhao H; Kitaura H; Bhattacharyya S; Brewer JA; Muglia LJ; Patrick Ross F; Teitelbaum SL
Ann N Y Acad Sci; 2007 Nov; 1116():335-9. PubMed ID: 18083935
[TBL] [Abstract][Full Text] [Related]
67. Hypoxia enhances glucocorticoid-induced apoptosis and cell cycle arrest via the PI3K/Akt signaling pathway in osteoblastic cells.
Zou W; Yang S; Zhang T; Sun H; Wang Y; Xue H; Zhou D
J Bone Miner Metab; 2015 Nov; 33(6):615-24. PubMed ID: 25230819
[TBL] [Abstract][Full Text] [Related]
68. Glucocorticoid induces osteonecrosis of the femoral head in rats through GSK3β-mediated osteoblast apoptosis.
Nie Z; Chen S; Peng H
Biochem Biophys Res Commun; 2019 Apr; 511(3):693-699. PubMed ID: 30827503
[TBL] [Abstract][Full Text] [Related]
69. Impaired cortical bone acquisition and osteoblast differentiation in mice with osteoblast-targeted disruption of glucocorticoid signaling.
Sher LB; Harrison JR; Adams DJ; Kream BE
Calcif Tissue Int; 2006 Aug; 79(2):118-25. PubMed ID: 16927049
[TBL] [Abstract][Full Text] [Related]
70. Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density.
Jia D; O'Brien CA; Stewart SA; Manolagas SC; Weinstein RS
Endocrinology; 2006 Dec; 147(12):5592-9. PubMed ID: 16935844
[TBL] [Abstract][Full Text] [Related]
71. Mechanisms of glucocorticoid action in bone.
Canalis E; Delany AM
Ann N Y Acad Sci; 2002 Jun; 966():73-81. PubMed ID: 12114261
[TBL] [Abstract][Full Text] [Related]
72. Molecular mechanisms of glucocorticoid-induced osteoporosis.
Patschan D; Loddenkemper K; Buttgereit F
Bone; 2001 Dec; 29(6):498-505. PubMed ID: 11728918
[TBL] [Abstract][Full Text] [Related]
73. Glucocorticoid-induced osteoporosis: an osteoblastic disease.
Migliaccio S; Brama M; Fornari R; Greco EA; Spera G; Malavolta N
Aging Clin Exp Res; 2007 Jun; 19(3 Suppl):5-10. PubMed ID: 18180599
[TBL] [Abstract][Full Text] [Related]
74. β-catenin promotes bone formation and suppresses bone resorption in postnatal growing mice.
Chen J; Long F
J Bone Miner Res; 2013 May; 28(5):1160-9. PubMed ID: 23188722
[TBL] [Abstract][Full Text] [Related]
75. Selective glucocorticoid receptor modulation maintains bone mineral density in mice.
Thiele S; Ziegler N; Tsourdi E; De Bosscher K; Tuckermann JP; Hofbauer LC; Rauner M
J Bone Miner Res; 2012 Nov; 27(11):2242-50. PubMed ID: 22714558
[TBL] [Abstract][Full Text] [Related]
76. Effect of glucocorticoid-induced osteoporotic-like conditions on osteoblast cell attachment to implant surface microtopographies.
Cho P; Schneider GB; Kellogg B; Zaharias R; Keller JC
Implant Dent; 2006 Dec; 15(4):377-85. PubMed ID: 17172956
[TBL] [Abstract][Full Text] [Related]
77. Molecular mechanisms of glucocorticoids on skeleton and bone regeneration after fracture.
Hachemi Y; Rapp AE; Picke AK; Weidinger G; Ignatius A; Tuckermann J
J Mol Endocrinol; 2018 Jul; 61(1):R75-R90. PubMed ID: 29588427
[TBL] [Abstract][Full Text] [Related]
78. Glucocorticoids inhibit osteocalcin transcription in osteoblasts by suppressing Egr2/Krox20-binding enhancer.
Leclerc N; Noh T; Khokhar A; Smith E; Frenkel B
Arthritis Rheum; 2005 Mar; 52(3):929-39. PubMed ID: 15751078
[TBL] [Abstract][Full Text] [Related]
79. Pulsed electromagnetic fields modify the adverse effects of glucocorticoids on bone architecture, bone strength and porous implant osseointegration by rescuing bone-anabolic actions.
Cai J; Shao X; Yang Q; Yang Y; Yan Z; Luo E; Feng X; Jing D
Bone; 2020 Apr; 133():115266. PubMed ID: 32044333
[TBL] [Abstract][Full Text] [Related]
80. Glucocorticoids suppress bone formation via the osteoclast.
Kim HJ; Zhao H; Kitaura H; Bhattacharyya S; Brewer JA; Muglia LJ; Ross FP; Teitelbaum SL
J Clin Invest; 2006 Aug; 116(8):2152-60. PubMed ID: 16878176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
